Select a Region
North America

Read our latest news!

Posted on 3月 6, 20243/6/24

Tonix Pharmaceuticals Selects EVERSANA to Support Launch Strategy and Commercialization Planning of Tonmya™ for the Management of Fibromyalgia

Posted on 2月 22, 20242/22/24

EVERSANA CONSULTING Named a Top Consulting Firm in Asia Pacific Region for the Second Consecutive Year

Posted on 2月 8, 20242/8/24

EVERSANA CONSULTING Named a Vault Top Ranked Consulting Firm in North America for the Third Consecutive Year

EVERSANA
Posted on 1月 11, 20241/11/24

EVERSANA Named 2024 BIG Innovation Award Winner for ACTICS eAccess  

Posted on 12月 19, 202312/19/23

Shorla Oncology & EVERSANA Announce U.S. Commercial Launch of FDA-Approved JYLAMVO, the First and Only Oral Methotrexate Solution Approved in the U.S. for Adults

EVERSANA
Posted on 12月 15, 202312/15/23

EVERSANA Recognized for Developing Multiple Top Innovations for 2023 by PM360 

Posted on 11月 27, 202311/27/23

EVERSANA Builds on Commitment to “Pharmatize” AI with Amazon Web Services, Introduces Transformative Medical & Regulatory Review Solution

EVERSANA
Posted on 11月 20, 202311/20/23

EVERSANA to Use Adobe Firefly for Enterprise in Creative Development & Modular Content Production for Life Sciences Marketing

EVERSANA
Posted on 11月 6, 202311/6/23

EVERSANA INTOUCH Named Global Independent Pharma Agency of the Year by London International Awards

Posted on 10月 31, 202310/31/23

Evoke Pharma & EVERSANA Unveil Cost Savings Real-World Data Demonstrating Meaningfully Reduced Healthcare Costs for Patients Using GIMOTI Over Oral Metoclopramide Presented at the American College of Gastroenterology 2023